These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16185879)

  • 1. Fluorine-substituted dihydrobicyclomycins: synthesis and biochemical and biological properties.
    Park BS; Widger W; Kohn H
    Bioorg Med Chem; 2006 Jan; 14(1):41-61. PubMed ID: 16185879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C(5)-C(5a)-modified bicyclomycins: synthesis, structure, and biochemical and biological properties.
    Vincent F; Srinivasan J; Santillán A; Widger WR; Kohn H
    J Org Chem; 2001 Apr; 66(7):2251-64. PubMed ID: 11281764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological properties.
    Brogan AP; Widger WR; Kohn H
    J Org Chem; 2003 Jul; 68(14):5575-87. PubMed ID: 12839449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the C(5)-C(5a) Exomethylene Group in Bicyclomycin: Synthesis, Structure, and Biochemical and Biological Properties.
    Park Hg HG; Zhang Z; Zhang X; Widger WR; Kohn H
    J Org Chem; 1996 Nov; 61(22):7764-7776. PubMed ID: 11667732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.
    Park HG; Zhang X; Moon HS; Zwiefka A; Cox K; Gaskell SJ; Widger WR; Kohn H
    Arch Biochem Biophys; 1995 Nov; 323(2):447-54. PubMed ID: 7487110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry.
    Brogan AP; Widger WR; Bensadek D; Riba-Garcia I; Gaskell SJ; Kohn H
    J Am Chem Soc; 2005 Mar; 127(8):2741-51. PubMed ID: 15725032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the C(6)-hydroxy group in bicyclomycin: synthesis, structure, and chemical, biochemical, and biological properties.
    Santillán A; Zhang X; Hardesty J; Widger WR; Kohn H
    J Med Chem; 1998 Mar; 41(7):1185-94. PubMed ID: 9544218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the location of bicyclomycin binding to the Escherichia coli transcription termination factor Rho.
    Riba I; Gaskell SJ; Cho H; Widger WR; Kohn H
    J Biol Chem; 1998 Dec; 273(51):34033-41. PubMed ID: 9852059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of fluorine position on the properties of fluorobenzoxaboroles.
    Adamczyk-Woźniak A; Cabaj MK; Dominiak PM; Gajowiec P; Gierczyk B; Lipok J; Popenda Ł; Schroeder G; Tomecka E; Urbański P; Wieczorek D; Sporzyński A
    Bioorg Chem; 2015 Jun; 60():130-5. PubMed ID: 26004751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective synthesis of a dioxa-bicyclo[3.2.1]octane SGLT2 inhibitor.
    Mascitti V; Préville C
    Org Lett; 2010 Jul; 12(13):2940-3. PubMed ID: 20527898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5a-formylbicyclomycin: studies on the bicyclomycin-Rho interaction.
    Vincent F; Widger WR; Openshaw M; Gaskell SJ; Kohn H
    Biochemistry; 2000 Aug; 39(31):9067-76. PubMed ID: 10924099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin.
    Skordalakes E; Brogan AP; Park BS; Kohn H; Berger JM
    Structure; 2005 Jan; 13(1):99-109. PubMed ID: 15642265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of fluorinated analogues of salicylihalamide.
    Sugimoto Y; Konoki K; Murata M; Matsushita M; Kanazawa H; Oishi T
    J Med Chem; 2009 Feb; 52(3):798-806. PubMed ID: 19117395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase.
    Moyse KA; Knight JS; Richardson JP
    J Mol Biol; 2000 Sep; 302(3):565-79. PubMed ID: 10986119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis for the mode of action of bicyclomycin.
    Kohn H; Widger W
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVI. Derivatives of 1-acetoxy-7,7-dimethylbicyclo[2.2.2]octan-5-one-2,3-dicarboximide.
    Kossakowski J; Hejchman E
    Acta Pol Pharm; 2003; 60(1):61-6. PubMed ID: 12848369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of levoglucosenone-derived ras activation inhibitors.
    Müller C; Gomez-Zurita Frau MA; Ballinari D; Colombo S; Bitto A; Martegani E; Airoldi C; van Neuren AS; Stein M; Weiser J; Battistini C; Peri F
    ChemMedChem; 2009 Apr; 4(4):524-8. PubMed ID: 19226500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of peptidomimetics based on substituted bicyclic 2-pyridones-targeting virulence of uropathogenic E. coli.
    Berg V; Sellstedt M; Hedenström M; Pinkner JS; Hultgren SJ; Almqvist F
    Bioorg Med Chem; 2006 Nov; 14(22):7563-81. PubMed ID: 16904898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal-1,4-dithio-2,3-dihydroxybutane chelates: novel inhibitors of the Rho transcription termination factor.
    Weber TP; Widger WR; Kohn H
    Biochemistry; 2003 Aug; 42(30):9121-6. PubMed ID: 12885245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative improved synthesis of (-)-norferruginine, a potent nAChR agonist.
    Wegge T; Schwarz S; Seitz G
    Pharmazie; 2000 Oct; 55(10):779-80. PubMed ID: 11082844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.